SCHEMBL4575588

SCHEMBL4575588

CCOC(=O)C(C)(C)Oc1ccc(CCN(Cc2ccc(OC(F)(F)F)cc2)c2ccc(C=O)cn2)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 2/20 0.41
PPARA Q07869 7/20 0.40
ABCB11 O95342 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
HTR2A P28223 1/20 0.40
PMP22 Q01453 1/20 0.40
TRPM8 Q7Z2W7 4/20 0.36
POLB P06746 1/20 0.36
GRM2 Q14416 1/20 0.35
PPARG P37231 5/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
OPRK1 P41145 1/20 0.34
PPARD Q03181 1/20 0.34
DAGLA Q9Y4D2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575876 0.91 FBP1 (0.40) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4574849 0.89 PPARA (0.42) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL6638554 0.89 PPARG (0.45) PPARATRPM8PPARGPPARD
SCHEMBL4574809 0.89 PPARA (0.41) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4576163 0.89 TRPM8 (0.43) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL4575178 0.89 PPARA (0.41) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4576149 0.87 PPARA (0.40) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4575496 0.87 PPARA (0.43) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4575411 0.85 FBP1 (0.39) FBP1PPARAABCB11CYP1A2CYP3A4
SCHEMBL4574835 0.85 PPARA (0.39) FBP1PPARAABCB11CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD FBP1 241/4885PPARA 2/4885ABCB11 358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.